CGEN 内幕交易 Insider Trades
CGEN 的 SEC Form 4 内幕交易记录 SEC Form 4 insider transaction records for CGEN
总交易 Total
62
买入 Buys
0
买入总额 Total Buys
-
卖出总额 Total Sells
$184K
| 信号 Signal | 内幕人 Insider | 职位 Title | 方向 Type | 股数 Shares | 价格 Price | 金额 Amount | 日期 Date | 信号原因 Reasons |
|---|---|---|---|---|---|---|---|---|
| ★★★★★(38) | OPHIR ERAN | President and CEO | 卖出 Sell | 5,000 | $3.20 | $16K | 2026-04-24 | CEO卖出, 董事卖出 |
| ★★★★★(38) | OPHIR ERAN | President and CEO | 卖出 Sell | 5,625 | $2.21 | $12K | 2026-04-01 | CEO卖出, 董事卖出 |
| ★★★★★(30) | OPHIR ERAN | President and CEO | 卖出 Sell | 5,000 | $2.76 | $14K | 2026-04-14 | CEO卖出, 董事卖出 |
| ★★★★★(16) | LEVINE ZURIT | SVP, Business Development | 卖出 Sell | 11,875 | $2.04 | $24K | 2026-03-26 | 高管卖出, 减持超20%持仓 |
| ★★★★★(8) | LEVINE ZURIT | SVP, Business Development | 卖出 Sell | 1,875 | $2.50 | $5K | 2026-07-09 | 高管卖出 |
| ★★★★★(8) | LEVINE ZURIT | SVP, Business Development | 卖出 Sell | 2,000 | $3.20 | $6K | 2026-04-24 | 高管卖出 |
| ★★★★★(8) | LEVINE ZURIT | SVP, Business Development | 卖出 Sell | 4,000 | $2.92 | $12K | 2026-04-24 | 高管卖出 |
| ★★★★★(8) | LEVINE ZURIT | SVP, Business Development | 卖出 Sell | 2,000 | $2.76 | $6K | 2026-04-14 | 高管卖出 |
| ★★★★★(8) | LEVINE ZURIT | SVP, Business Development | 卖出 Sell | 3,125 | $2.56 | $8K | 2026-04-10 | 高管卖出 |
| ★★★★★(8) | LEVINE ZURIT | SVP, Business Development | 卖出 Sell | 2,000 | $2.48 | $5K | 2026-04-10 | 高管卖出 |
| ★★★★★(8) | LEVINE ZURIT | SVP, Business Development | 卖出 Sell | 5,375 | $2.42 | $13K | 2026-04-08 | 高管卖出 |
| ★★★★★(8) | LEVINE ZURIT | SVP, Business Development | 卖出 Sell | 2,500 | $2.30 | $6K | 2026-04-07 | 高管卖出 |
| ★★★★★(8) | LEVINE ZURIT | SVP, Business Development | 卖出 Sell | 3,500 | $2.20 | $8K | 2026-04-01 | 高管卖出 |
| ★★★★★(8) | LEVINE ZURIT | SVP, Business Development | 卖出 Sell | 24,375 | $2.06 | $50K | 2026-03-26 | 高管卖出 |
| ★★★★★(0) | MAHLER MICHELLE | Chief Medical Officer | 卖出 Sell | 18,000 | - | - | 2026-07-29 | |
| ★★★★★(0) | HALEVY GILEAD | - | 卖出 Sell | 7,500 | - | - | 2026-07-29 | |
| ★★★★★(0) | KREDO RUSSO SHARON | SVP, Research & Discovery | 卖出 Sell | 24,000 | - | - | 2026-07-29 | |
| ★★★★★(0) | FERRE PIERRE | Chief Operating Officer | 卖出 Sell | 70,000 | - | - | 2026-07-29 | |
| ★★★★★(0) | PERRY ERAN | - | 卖出 Sell | 10,000 | - | - | 2026-07-29 | |
| ★★★★★(0) | LIVNAT SAVITZKY KINNERET | - | 卖出 Sell | 7,500 | - | - | 2026-07-29 | |
| ★★★★★(0) | ZWEIFACH SANFORD S | - | 卖出 Sell | 7,500 | - | - | 2026-07-29 | |
| ★★★★★(0) | HUKKELHOVEN MATHIAS | - | 卖出 Sell | 10,000 | - | - | 2026-07-29 | |
| ★★★★★(0) | LIVNAT SAVITZKY KINNERET | - | 卖出 Sell | 10,000 | - | - | 2026-07-29 | |
| ★★★★★(0) | PERRY ERAN | - | 卖出 Sell | 7,500 | - | - | 2026-07-29 | |
| ★★★★★(0) | ZWEIFACH SANFORD S | - | 卖出 Sell | 10,000 | - | - | 2026-07-29 | |
| ★★★★★(0) | SILBERMAN DAVID | Chief Financial Officer | 卖出 Sell | 19,500 | - | - | 2026-07-29 | |
| ★★★★★(0) | HUKKELHOVEN MATHIAS | - | 卖出 Sell | 7,500 | - | - | 2026-07-29 | |
| ★★★★★(0) | OPHIR ERAN | President and CEO | 卖出 Sell | 200,000 | - | - | 2026-07-29 | |
| ★★★★★(0) | LEVINE ZURIT | SVP, Business Development | 卖出 Sell | 18,000 | - | - | 2026-07-29 | |
| ★★★★★(0) | MAHLER MICHELLE | Chief Medical Officer | 卖出 Sell | 13,500 | - | - | 2026-07-29 | |
| ★★★★★(0) | LEVINE ZURIT | SVP, Business Development | 卖出 Sell | 24,000 | - | - | 2026-07-29 | |
| ★★★★★(0) | KREDO RUSSO SHARON | SVP, Research & Discovery | 卖出 Sell | 18,000 | - | - | 2026-07-29 | |
| ★★★★★(0) | HALEVY GILEAD | - | 卖出 Sell | 10,000 | - | - | 2026-07-29 | |
| ★★★★★(0) | COHEN-DAYAG ANAT | - | 卖出 Sell | 100,000 | - | - | 2026-07-29 | |
| ★★★★★(0) | SILBERMAN DAVID | Chief Financial Officer | 卖出 Sell | 26,000 | - | - | 2026-07-29 | |
| ★★★★★(0) | LEVINE ZURIT | SVP, Business Development | 卖出 Sell | 1,875 | - | - | 2026-07-09 | |
| ★★★★★(0) | LEVINE ZURIT | SVP, Business Development | 卖出 Sell | 2,000 | $1.15 | $2K | 2026-04-24 | |
| ★★★★★(0) | OPHIR ERAN | President and CEO | 卖出 Sell | 5,000 | $0.83 | $4K | 2026-04-24 | |
| ★★★★★(0) | LEVINE ZURIT | SVP, Business Development | 卖出 Sell | 2,000 | - | - | 2026-04-14 | |
| ★★★★★(0) | OPHIR ERAN | President and CEO | 卖出 Sell | 5,000 | $0.83 | $4K | 2026-04-14 | |
| ★★★★★(0) | LEVINE ZURIT | SVP, Business Development | 卖出 Sell | 2,000 | $1.15 | $2K | 2026-04-10 | |
| ★★★★★(0) | LEVINE ZURIT | SVP, Business Development | 卖出 Sell | 1,125 | - | - | 2026-04-10 | |
| ★★★★★(0) | LEVINE ZURIT | SVP, Business Development | 卖出 Sell | 1,000 | - | - | 2026-04-08 | |
| ★★★★★(0) | LEVINE ZURIT | SVP, Business Development | 卖出 Sell | 4,375 | - | - | 2026-04-08 | |
| ★★★★★(0) | LEVINE ZURIT | SVP, Business Development | 卖出 Sell | 2,500 | $0.83 | $2K | 2026-04-07 | |
| ★★★★★(0) | OPHIR ERAN | President and CEO | 卖出 Sell | 5,625 | - | - | 2026-04-01 | |
| ★★★★★(0) | LEVINE ZURIT | SVP, Business Development | 卖出 Sell | 2,500 | $0.83 | $2K | 2026-04-01 | |
| ★★★★★(0) | LEVINE ZURIT | SVP, Business Development | 卖出 Sell | 1,000 | - | - | 2026-04-01 | |
| ★★★★★(0) | LEVINE ZURIT | SVP, Business Development | 卖出 Sell | 11,875 | - | - | 2026-03-26 | |
| ★★★★★(0) | LIVNAT SAVITZKY KINNERET | - | 卖出 Sell | 0 | - | - | 2026-03-18 | |
| ★★★★★(0) | OPHIR ERAN | President and CEO | 卖出 Sell | 0 | - | - | 2026-03-18 | |
| ★★★★★(0) | ZWEIFACH SANFORD S | - | 卖出 Sell | 0 | - | - | 2026-03-18 | |
| ★★★★★(0) | FERRE PIERRE | Chief Operating Officer | 卖出 Sell | 0 | - | - | 2026-03-18 | |
| ★★★★★(0) | PERRY ERAN | - | 卖出 Sell | 0 | - | - | 2026-03-18 | |
| ★★★★★(0) | HOLCOMB MICHELE | - | 卖出 Sell | 0 | - | - | 2026-03-18 | |
| ★★★★★(0) | SILBERMAN DAVID | Chief Financial Officer | 卖出 Sell | 0 | - | - | 2026-03-18 | |
| ★★★★★(0) | COHEN-DAYAG ANAT | - | 卖出 Sell | 0 | - | - | 2026-03-18 | |
| ★★★★★(0) | HUKKELHOVEN MATHIAS | - | 卖出 Sell | 0 | - | - | 2026-03-18 | |
| ★★★★★(0) | KREDO RUSSO SHARON | SVP, Research & Discovery | 卖出 Sell | 0 | - | - | 2026-03-18 | |
| ★★★★★(0) | HALEVY GILEAD | - | 卖出 Sell | 0 | - | - | 2026-03-18 | |
| ★★★★★(0) | LEVINE ZURIT | SVP, Business Development | 卖出 Sell | 0 | - | - | 2026-03-18 | |
| ★★★★★(0) | MAHLER MICHELLE | Chief Medical Officer | 卖出 Sell | 0 | - | - | 2026-03-18 |